These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997. Hermann RC; Yang D; Ettner SL; Marcus SC; Yoon C; Abraham M Psychiatr Serv; 2002 Apr; 53(4):425-30. PubMed ID: 11919355 [TBL] [Abstract][Full Text] [Related]
3. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia. Luo RD; Belleti DA; Tran D; Arcona S; Salen PN Int J Psychiatry Med; 2002; 32(3):261-9. PubMed ID: 12489701 [TBL] [Abstract][Full Text] [Related]
12. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Broekema WJ; de Groot IW; van Harten PN Pharm World Sci; 2007 Jun; 29(3):126-30. PubMed ID: 17333501 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors. Sankaranarayanan J; Puumala SE Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297 [TBL] [Abstract][Full Text] [Related]
15. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Owen RR; Feng W; Thrush CR; Hudson TJ; Austen MA Psychiatr Serv; 2001 Nov; 52(11):1523-5. PubMed ID: 11684751 [TBL] [Abstract][Full Text] [Related]
16. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals. Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557 [TBL] [Abstract][Full Text] [Related]
17. Effects of antipsychotic medication on psychiatric service utilization and cost. Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980 [TBL] [Abstract][Full Text] [Related]
18. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. Kogut SJ; Yam F; Dufresne R J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230 [TBL] [Abstract][Full Text] [Related]
19. Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications. Sernyak MJ; Leslie D; Rosenheck R Am J Psychiatry; 2003 Feb; 160(2):310-5. PubMed ID: 12562578 [TBL] [Abstract][Full Text] [Related]
20. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice. Paton C; Bhatti S; Purandare K; Roy A; Barnes T BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]